ADAMTS13 and thrombotic thrombocytopenic purpura: However, biological investigations may not confirm the clinical diagnosis as at least 10-25% of TTP patients have normal ADAMTS13 activity and 30% of aHUS patients have no complement anomalies, suggesting the presence of unknown physiopathological mechanisms [16,24,25].